SWOT Analysis for Jaguar Health Inc

Positive Breakout Third Resistance ( LTP > R3)
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over Half Year (6 Months)
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain
Highest Recovery from 52 Week Low

Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Stocks Underperforming their Industry Price Change in the Quarter